UK government
UK highlights life sciences’ key role in post-COVID recovery
Phil Taylor
ABPI, BIA, Life Sciences, NHS, UK, UK government
0 Comment
Patients/ Views & Analysis/ Views and analysis
Building a better future for people with rare diseases in all four UK nations
Amanda Barrell
Genetic Alliance UK, Rare Disease Day, rare disease framework, Rare diseases, UK government
0 Comment
Labour accuses government of cronyism in COVID-19 contracts
Phil Taylor
coronavirus, COVID-19, politics, PPE, UK, UK government
0 Comment
Articles/ Healthcare/ Pharma Market Access/ Sales and Marketing/ UK & Europe/ Views and analysis
Hung parliament: who will pharma negotiate with on new PPRS?
Leela Barham
cabinet reshuffle, Drug pricing, General election, hung parliament, PPRS, UK government
0 Comment
Who could influence the makeup of the new PPRS?
Articles/ Pharma Market Access/ UK & Europe/ Views and analysis
New UK law to control generic drug prices – implications for pharma
Marco Ricci
Drug pricing, Drug regulation, market access, NHS, UK government
0 Comment
The aims and implications of the Health Service Medical Supplies (Costs) Act 2017.